MaritimeBoundaryDispute
|
|
appearance as argument number 1 |
(documentation Lisdexamfetamine EnglishLanguage "Lisdexamfetamine, sold under the brand name Vyvanse among others, is a medication that is a derivative of Amphetamine. It is mainly used to treat attention deficit hyperactivity disorder (ADHD) in people over the age of five as well as moderate-to-severe binge eating disorder in adults. Lisdexamfetamine is taken by mouth. In the UnitedKingdom, it is usually less preferred than methylphenidate. Its effects generally begin within 2 hours and last for up to 14 hours. [from Wikipedia]") | Medicine.kif 3969-3976 | |
(subclass Lisdexamfetamine Medicine) | Medicine.kif 3966-3966 | Lisdexamfetamine ist eine teilkategorie von Medicine |
(subclass Lisdexamfetamine Stimulant) | Medicine.kif 3967-3967 | Lisdexamfetamine ist eine teilkategorie von Stimulant |
appearance as argument number 2 |
(diseaseMedicine AttentionDeficitHyperactivityDisorder Lisdexamfetamine Ingesting) | Medicine.kif 3979-3979 | diseaseMedicine AttentionDeficitHyperactivityDisorder, Lisdexamfetamine and Ingesting |
(subclass Vyvanse Lisdexamfetamine) | Medicine.kif 3981-3981 | Vyvanse ist eine teilkategorie von Lisdexamfetamine |
(termFormat EnglishLanguage Lisdexamfetamine "lisdexamfetamine") | Medicine.kif 3978-3978 |